Wednesday, April 24, 2024

GW Pharma

Why Approval Of Cannabis-Based Epilepsy Drug May Not Be A Win

A Food and Drug Administration panel recommended approval of a drug made of cannabidiol on April 19 to treat two types of epilepsy.

Marijuana-Based Epilepsy Drug Is Close To FDA Approval

A marijuana-based drug received a unanimous thumbs-up from a panel of experts organized by the Food and Drug Administration.
[td_block_social_counter custom_title=”Follow Us” facebook=”https://www.facebook.com/getfreshtoast/” block_template_id=”td_block_template_2″ f_header_font_size=”eyJhbGwiOiIyMiIsInBvcnRyYWl0IjoiMjEifQ==” f_header_font_line_height=”eyJhbGwiOiIyNnB4IiwicG9ydHJhaXQiOiIyNXB4In0=” f_header_font_weight=”900″ f_header_font_family=”325″ twitter=”https://www.linkedin.com/company/the-fresh-toast” googleplus=”#” instagram=”https://www.instagram.com/getfreshtoast/” manual_count_facebook=”123000″ manual_count_twitter=”6500″ manual_count_instagram=”7000″]

Latest Articles

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.